De Novo Anti-Type VII Collagen Antibodies in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology - United Kingdom
doi 10.1038/jid.2013.475
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Gentamicin Induces Functional Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Patients

Journal of Clinical Investigation
Medicine
2017English

390 miR-29 Regulates Type VII Collagen in Individuals With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Recessive Dystrophic Epidermolysis Bullosa Inversa

2020English

251 Natural History of Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Genetic Linkage of Type VII Collagen (COL7A1) to Dominant Dystrophic Epidermolysis Bullosa in Families With Abnormal Anchoring Fibrils.

Journal of Clinical Investigation
Medicine
1992English

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

New England Journal of Medicine
Medicine
2010English

935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Image Gallery: Multiple Localized Lipoatrophy in Recessive Dystrophic Epidermolysis Bullosa

British Journal of Dermatology
DermatologyMedicine
2019English

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy